ECSP077423A - Coadministración de tigeciclina y digoxin - Google Patents

Coadministración de tigeciclina y digoxin

Info

Publication number
ECSP077423A
ECSP077423A EC2007007423A ECSP077423A ECSP077423A EC SP077423 A ECSP077423 A EC SP077423A EC 2007007423 A EC2007007423 A EC 2007007423A EC SP077423 A ECSP077423 A EC SP077423A EC SP077423 A ECSP077423 A EC SP077423A
Authority
EC
Ecuador
Prior art keywords
digoxin
tigecicline
coadministration
tigecycline
administration
Prior art date
Application number
EC2007007423A
Other languages
English (en)
Inventor
Donald G Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP077423A publication Critical patent/ECSP077423A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

La invención se relaciona con el tratamiento de infecciones bacterianas con tigeciclina y la insuficiencia cardiaca con digoxin mediante la coadministración a un humano que lo necesita.
EC2007007423A 2004-10-28 2007-04-27 Coadministración de tigeciclina y digoxin ECSP077423A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
ECSP077423A true ECSP077423A (es) 2007-05-30

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007423A ECSP077423A (es) 2004-10-28 2007-04-27 Coadministración de tigeciclina y digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (es)
EP (1) EP1804807B1 (es)
JP (1) JP2008518911A (es)
KR (1) KR20070069182A (es)
CN (1) CN101039679A (es)
AT (1) ATE415973T1 (es)
AU (1) AU2005310306A1 (es)
BR (1) BRPI0517406A (es)
CA (1) CA2582089A1 (es)
CR (1) CR9073A (es)
DE (1) DE602005011468D1 (es)
EC (1) ECSP077423A (es)
IL (1) IL182681A0 (es)
MX (1) MX2007005163A (es)
NO (1) NO20071706L (es)
RU (1) RU2007112409A (es)
WO (1) WO2006060084A2 (es)
ZA (1) ZA200703441B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101354093B1 (ko) * 2005-03-14 2014-01-24 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
WO2018140093A1 (en) 2017-01-27 2018-08-02 Obrien Christopher F Methods for the administration of certain vmat2 inhibitors
TW201919622A (zh) 2017-09-21 2019-06-01 美商紐羅克里生物科學有限公司 高劑量戊苯那嗪（valbenazine）調配物及組合物、方法以及相關套組
AU2017435893B2 (en) * 2017-10-10 2023-06-29 Neurocrine Biosciences, Inc Methods for the administration of certain VMAT2 inhibitors

Also Published As

Publication number Publication date
ATE415973T1 (de) 2008-12-15
EP1804807B1 (en) 2008-12-03
MX2007005163A (es) 2007-06-26
RU2007112409A (ru) 2008-12-10
CR9073A (es) 2007-08-28
CA2582089A1 (en) 2006-06-08
ZA200703441B (en) 2008-09-25
CN101039679A (zh) 2007-09-19
US20060094668A1 (en) 2006-05-04
JP2008518911A (ja) 2008-06-05
WO2006060084A2 (en) 2006-06-08
DE602005011468D1 (de) 2009-01-15
KR20070069182A (ko) 2007-07-02
NO20071706L (no) 2007-05-24
BRPI0517406A (pt) 2008-10-07
EP1804807A2 (en) 2007-07-11
AU2005310306A1 (en) 2006-06-08
WO2006060084A3 (en) 2006-07-20
IL182681A0 (en) 2007-09-20

Similar Documents

Publication Publication Date Title
ECSP077423A (es) Coadministración de tigeciclina y digoxin
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
CL2009001099A1 (es) Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune.
UY29170A1 (es) Adeninas sustituidas y usos de las mismas
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
DK1809661T3 (da) Humant interferon-beta-mutein
GT200500266A (es) Nuevos derivados de pirimidina y su uso
NI200800176A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de la depresión
AR109263A2 (es) Composición que comprende moxidectina
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
UY29189A1 (es) Nonadepsipeptidos acilados ii
ECSP10010464A (es) Uso de ranolazina para el tratamiento de enfermedades cardiovasculares
EA200602002A1 (ru) Применение спинозинов для заживления ран
EA201000864A1 (ru) Фенилоксетанильные производные
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
EA200802136A1 (ru) Лечение меланомы
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
UY28951A1 (es) Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas
CL2010001589A1 (es) Compuestos derivados de 3-ciano-pirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
CL2011001399A1 (es) Compuestos derivados de morfina-6-glucuronido; medicamento; composicion farmaceutica que los comprende; compuestos intermediarios; y su uso en el tratamiento o prevencion del dolor.
CL2011001493A1 (es) Uso local de estriol para un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres.